Hove-Skovsgaard, Malene
Abildgaard, Julie
Gelpi, Marco
Gaardbo, Julie Christine
Kolte, Lilian
Ullum, Henrik
Trøseid, Marius
Lindegaard, Birgitte
Nielsen, Susanne Dam http://orcid.org/0000-0001-6391-7455
Funding for this research was provided by:
Novo Nordisk Fonden
Rigshospitalet
Augustinus Fonden
Article History
Received: 15 October 2019
Accepted: 5 November 2020
First Online: 25 November 2020
Ethics approval and consent to participate
: The study was performed in accordance with the Declaration of Helsinki and approved by the local ethical committee on health research ethics, “Videnskabsetisk Komitee, Region Hovedstaden” which belongs to The Danish National Committee on Health Research Ethics (H-4-2012-076 CIM VEK) and the Danish Data Protection Agency. All participants signed a written consent when included in the study.
: Not applicable.
: MG: unrestricted travel grants from Gilead; SDN: Unrestricted research grants from Novo Nordisk Foundation, Lundbeck Foundation, Augustinus Foundation, Rigshospitalet Research Council. Travelling grants from Gilead and GSK/ViiV. Advisory board activity for Gilead and GSK/ViiV. All other authors have no competing interests. Part of the data were presented as a poster presentation at Conference on Retroviruses and Opportunistic Infections (CROI), Seattle, February 23 to February 26, 2015.